{"organizations": [], "uuid": "08efd343c612f8f727e93d1e3a78924e3c01cfaf", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/shire-ma-takeda-pharma-offer/takeda-ups-shire-offer-to-47-pounds-a-share-idUSFWN1RX0SK", "country": "US", "domain_rank": 408, "title": "Takeda ups Shire offer to 47 pounds-a-share", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-20T17:00:00.000+03:00", "replies_count": 0, "uuid": "08efd343c612f8f727e93d1e3a78924e3c01cfaf"}, "author": "", "url": "https://www.reuters.com/article/shire-ma-takeda-pharma-offer/takeda-ups-shire-offer-to-47-pounds-a-share-idUSFWN1RX0SK", "ord_in_thread": 0, "title": "Takeda ups Shire offer to 47 pounds-a-share", "locations": [], "entities": {"persons": [{"name": "takeda", "sentiment": "negative"}, {"name": "paul sandle", "sentiment": "none"}, {"name": "kate holton", "sentiment": "none"}], "locations": [{"name": "london", "sentiment": "none"}, {"name": "japan", "sentiment": "none"}], "organizations": [{"name": "shire", "sentiment": "negative"}, {"name": "takeda", "sentiment": "negative"}, {"name": "takeda pharmaceutical co ltd", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 20, 2018 / 2:00 PM / in 14 minutes Takeda ups Shire offer to 47 pounds-a-share   \nLONDON, April 20 (Reuters) - Japan’s Takeda Pharmaceutical Co Ltd increased its offer for Shire to 47 pounds a share on Friday after its three previous bids - the last at 46.50 pounds - were rejected by the rare disease drugs specialist. \nShire’s shares were trading at 38.71 pounds shortly after Takeda confirmed its latest bid. Reporting by Paul Sandle; editing by Kate Holton", "external_links": [], "published": "2018-04-20T17:00:00.000+03:00", "crawled": "2018-04-20T17:19:08.007+03:00", "highlightTitle": ""}